Böll, Boris
Subklewe, Marion
von Bergwelt-Baildon, Michael
Article History
Received: 20 January 2020
Accepted: 6 March 2020
First Online: 30 March 2020
Conflicts of interest
: BB has received research grants from Astellas, Gilead Sciences and MSD and speaker fees from Astellas, Celgene, Johnson & Johnson, Gilead Sciences, MSD, Novartis and Takeda and has been a consultant to Gilead Sciences, MSD, Novartis and Takeda.